Akoustis Technologies, Inc.

As of July 8, 2024, Akoustis Technologies, Inc. has deteriorated to a "does not qualify" valuation grade due to being overvalued with a P/E ratio of 0.0000 and a -100% return year-to-date, contrasting sharply with its peer PCTEL, Inc., which has a fair rating and a P/E of 31.3254.

As of September 13, 2019, Akoustis Technologies, Inc. is considered a risky investment due to its negative performance metrics, including a P/E ratio of -0.0003, an EV to EBITDA ratio of -0.95, and a 99.92% stock decline over the past year, significantly underperforming compared to its peers.

As of May 27, 2025, the technical trend is mildly bearish, with daily moving averages and monthly KST confirming a bearish outlook despite some bullish signals in the monthly RSI and MACD.

As of March 2022, the management team of Akoustis Technologies, Inc. includes Mr. Arthur Geiss and Dr. Jerry Neal as Co-Chairmen, Mr. Jeffrey Shealy as CEO, and several independent directors: Prof. Steven Denbaars, Mr. J. Michael McGuire, Mr. Jeffrey McMahon, and Ms. Suzanne Rudy. This team is responsible for the company's strategic direction and operations.

As of Jun 18, Akoustis Technologies, Inc. has a market capitalization of 0.02, classifying it as a Micro Cap company, with recent net sales of 29.42 million and a net profit loss of 154.24 million. As of Jun 24, shareholder's funds are at -57.09 million, and total assets are 69.74 million.